Solving Tableting and Tooling Problems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Solving Tableting and Tooling Problems
Adopting a seven-step process to maintenance and storage improves tableting quality.


Pharmaceutical Technology
Volume 37, Issue 2

Applying the process to tableting problems

Common problems can be identified and resolved by using the seven-step process.


Figure 1: Typical handling damage to a delicate punch-tip edge.
Damage to the punch-tip edge. Punch-tip edges are very delicate, and damage in the form of nicks and bruises can cause burrs and occasionally chipping (see Figure 1). These defects can lead to more serious failures, such as punch-tip breakage. Experience tells us that approximately 80% of damage to punches and dies is usually caused accidentally when handling the punches during the production and tool-care processes. Damage can occur, for example, when loading or unloading the tools in the tablet press, during transportation of the tooling, during storage, or while cleaning or polishing the tools. By adopting Steps 1 (Clean) and 2 (Assess) of the seven-step process, this type of damage can be identified and, by repeating the assessment throughout the process, we may recognize the main causes. If the damage is only slight, it may be possible to use Step 3 (Repair) to repair the damage, by removing the burrs and repolishing the tip edges to a good usable condition, thus ensuring consistent tablet appearance.


Figure 2: Typical head wear.
Head wear. Those areas of a punch that are in contact with other parts of the tablet press and are subjected to high-speed, frictional and compaction forces are typically prone to wear. An example is the head "dwell" flat, which is in contact with the precompression and main-compression rollers (see Figure 2). Premature wear should be investigated. Wear may be attributable to various causes, but commonly it is due to punch tightness and/or poor lubrication. Again this can be identified during Step 2 (Assess). Any light wear can be removed by remedial polishing through Step 3 (Repair). Polishing should be followed by measurement of the critical working length during Step 4 (Measure) thereby ensuring that the punches are within an acceptable tolerance range for good tablet weight and thickness control. Wear to the head angle from the cam track can also be a result of tight punches or lack of lubrication, and this wear can also be monitored and repaired as above.


Figure 3: Typical die-bore ringing.
Die-bore wear. Die-bore wear or "ringing" (see Figure 3) is another common defect that can lead to problems such as tablet "capping" and tablet-ejection issues, which result in wasted product and reduced tablet output. Ringing is caused by abrasive wear and deformation from continuous forces acting on the face of the die bore. This damage is accelerated when compressing hard and abrasive granules found in some formulations, particularly vitamins and minerals. This wear can be identified using visual inspection during Step 2 (Assess), but precise equipment is also available to measure and monitor this wear Step 4 (Measure). Physical die-condition monitoring can result in early diagnosis before the defect has a negative effect on tablet output.


Figure 4: Sticking (i.e., product adhering to the punch tip face).
Sticking and picking. When in a new condition, the surfaces of tablet-punch faces are usually polished to a high mirror finish. These surfaces, however, can deteriorate over a period of time due to the continuous compaction of granules, which can lead to tableting defects such as "picking" and "sticking" (see Figure 4) brought about by adhesion of the product to the now rough finish. This deterioration can be identified during assessment (Step 2, Assess). The product can be cleaned off with an efficient cleaning system (Step 1, Clean), and the finish can be improved/repaired by using a remedial polishing process as in Step 3 (Repair). With frequent light polishing using an automated polishing system (Step 5, Polish), a smooth and efficient surface can be maintained.

Conclusion

The seven-step process is a logical sequence to follow when tooling has been used and removed from the tablet press. Each of the steps can be conducted in isolation, if necessary, and go some way towards extending tooling life, while at the same time allowing for the planned and scheduled replacement of tooling.

Trevor Higgins is a technical expert at I Holland, tel. 44 0 115 9726153,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here